If you’d asked most doctors in early 2020 what they thought about hydroxychloroquine, you probably would’ve gotten a shrug. It was a workhorse: a malaria drug with a decent safety record, prescribed for decades, and also used for rheumatoid arthritis and lupus. No one would have guessed it would become the hottest—and most controversial—pill on the planet.
So, what happened? Why did hydroxychloroquine, after 70 years as a reliable treatment, suddenly get yanked from pharmacy shelves and painted as dangerous when COVID-19 hit? And what’s the truth behind those viral stories that it could “kill COVID within hours”?
Hydroxychloroquine: A Brief History
Let’s start with the basics. Hydroxychloroquine (HCQ) is a synthetic derivative of chloroquine, itself discovered in the 1930s and used extensively to treat malaria. Over the decades, millions of people—travelers, soldiers, and villagers in malaria zones—took these drugs. Side effects exist, sure, but for most, it was seen as relatively safe, especially when used short-term. By 2020, HCQ was a staple in rheumatology clinics and on the World Health Organization’s list of essential medicines.
COVID-19: The Miracle Drug Narrative
When the COVID-19 pandemic exploded, everyone was desperate for a treatment. Early lab studies showed that hydroxychloroquine could block the coronavirus from entering cells. Doctors in China and France reported anecdotal improvements in patients. The drug was cheap, widely available, and familiar. Soon, it was being touted by politicians and media personalities as a potential “cure.” Some doctors prescribed it off-label, and pharmacies saw a run on the drug.
But here’s the catch: “in vitro” (test tube) results don’t always translate to “in vivo” (real world) success. And the initial clinical data was spotty—small, often poorly designed studies, some later found to have major flaws or even retracted. No robust, peer-reviewed research showed that HCQ could reliably “kill COVID within hours” in human patients (NIH).
The Backlash and Demise
As more rigorous studies rolled in, the picture changed. Multiple large, randomized controlled trials—including those by the National Institutes of Health and the World Health Organization—found that hydroxychloroquine did not reduce COVID-19 mortality or speed recovery. In some cases, especially at high doses or in vulnerable patients, it increased the risk of heart rhythm problems (FDA).
Regulators reacted. The FDA, which had granted emergency use authorization for HCQ in March 2020, revoked it by June. The World Health Organization halted its trials. Pharmacies and hospitals pulled back as the evidence mounted that the risks outweighed the (unproven) benefits (WHO).
Why Was It “Demonized”?
The answer is complicated. Part of it was political: the drug became a lightning rod in the U.S., promoted by one camp as a miracle and dismissed by another as snake oil. This polarized debate often crowded out scientific nuance. Misinformation spread rapidly, fueled by social media and anecdotal reports rather than solid data (Nature).
But the scientific reason for the backlash was straightforward: large, controlled studies failed to show benefit, and the risks—especially heart complications—were real. The “demonization” was, for the most part, driven by the need to protect patients from unproven and potentially dangerous therapies, not by any grand conspiracy. One with knowledge has to ask IF this is true ...
How did large clinical trials suddenly become implemented and quickly available to prove that hydroxychloroquine wasn't effective against covid when they normally take years? And ...
WHY were doctors like Simone Gold, Peter McCullough and others criticized, ostracized, even jailed (Simone Gold) for speaking out against hospital protocols such as Remdesivir and ventolators? And why did Rashid Buttar, D.O. die of possible poisoning after claiming that deaths had spiked after the rollout of the covid vaccine?
Has Hydroxychloroquine Been Taken Off the Market?
No, not entirely. Hydroxychloroquine is still available for approved uses like lupus, rheumatoid arthritis, and malaria in many countries. What changed is that its use for COVID-19 is now strongly discouraged outside of clinical trials, and off-label prescriptions have plummeted (CDC).
The Takeaway
Hydroxychloroquine wasn’t “demonized” because it was a cheap, effective cure. It was scrutinized because, when tested carefully, it just didn’t live up to the hype for COVID-19—and it could cause real harm. It’s still an important drug for certain diseases, but it’s not the COVID silver bullet many hoped for. The lesson? In a pandemic, good data—not anecdotes or politics—should guide our choices.
Credits:
- National Institutes of Health: COVID-19 Treatment Guidelines: Hydroxychloroquine
- U.S. Food and Drug Administration: FDA Revokes Emergency Use Authorization for Hydroxychloroquine
- World Health Organization: WHO Discontinues Hydroxychloroquine in COVID-19 Trials
- Nature: The Story of Hydroxychloroquine and COVID-19
- Centers for Disease Control and Prevention: Hydroxychloroquine for Malaria



